adriamycinol

Known as: 13-dihydrodoxorubicin, doxorubicinol 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1976-2018
05101519762018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
BACKGROUND In the fight against cancer, new drug delivery systems are attractive to improve drug targeting of tumors, maximize… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Doxorubicin is a highly effective antineoplastic agent, but it can produce the serious side effects of acute cardiac injury and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Doxorubicinol (dxol) is the major metabolite formed in the hearts of cancer patients being treated with the widely used… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
PURPOSE We performed a pharmacologic investigation of paclitaxel (PTX) infused over 3 hours and bolus doxorubicin (DOX) to assess… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
PURPOSE To study the effects of cyclosporine (CsA), a modulator of multidrug resistance (MDR), on the pharmacokinetics and… (More)
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Doxorubicin (former generic name, adriamycin), a highly effective anticancer drug, produces cardiotoxicity, which limits its… (More)
Is this relevant?
Highly Cited
1988
Highly Cited
1988
A study was carried out to examine the effect, if any, of obesity on doxorubicin pharmacokinetics. Body weight was found to be… (More)
Is this relevant?
1987
1987
Doxorubicin (adriamycin) is a highly effective cancer chemotherapeutic drug but its clinical utility is limited by its… (More)
  • figure 1
  • figure 2
  • table I
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1983
Highly Cited
1983
The plasma pharmacokinetics of Adriamycin and adriamycinol following a 15-min infusion of 75 mg/sq m of Adriamycin were studied… (More)
  • table 1
  • table 2
Is this relevant?
1983
1983
Adriamycin was administered by IV injection to seven patients with various solid tumors at a dose of 30 mg/m2 during successive… (More)
  • table 1
  • table 2
  • figure 2
  • table 3
  • figure 1
Is this relevant?